Can Fite Biopharma (CANF) Stock Price, Quote, News & History

Q: What sector and industry does Can Fite Biopharma (CANF) operate in?

Can Fite Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

Comments

Can Fite Biopharma (CANF) Stock Price, Quote, News & History

CANFAMEX

Logo brought to you by Benzinga Data

Trade with Public

$4.05

-0.08-1.94%

At close: Feb 3, 4:00 PM EST

Overview

News Earnings Analyst Ratings Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$4.13

Close

$4.05

Volume / Avg.

21.94K / 29.87K

Day Range

$4.00 - $4.17

52 Wk Range

3.63 - 6.99K

Market Cap

$5.30M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

21

Short Interest

310.74%

Days to Cover

1

Recent Can Fite Biopharma Ltd News

Why Aptevo Therapeutics Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Avi Kapoor

Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

UiPath, Ramaco Resources And 3 Stocks To Watch Heading Into Wednesday

U.S. stock futures slightly lower. UiPath joins S&P Midcap 400, Agios receives FDA approval, Can Fite Biopharma announces reverse split.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-8.35M

Investing Cash Flow (TTM)

-2.00K

Financing Cash Flow (TTM)

10.08M

Free Cash Flow (TTM)

-8.36M

Capital Expenditure (TTM)

-2.00K

Net Change in Cash (TTM)

1.73M

Analyst Trends and Forecast

2

Sep 25

2

Nov 25

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$722.83K

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.65

PB Ratio (TTM)

1.29

Earnings Yield % (TTM)

0.00%

Earnings Yield % (FWD)

-21.79%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.20

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$6.45M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$4.13

Close

$4.05

Volume / Avg.

21.94K / 29.87K

Day Range

$4.00 - $4.17

52 Wk Range

3.63 - 6.99K

Market Cap

$5.30M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

21

Short Interest

310.74%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and rela...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Can Fite Biopharma (CANF) stock?

A

You can purchase shares of Can Fite Biopharma (AMEX:CANF) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Can Fite Biopharma (CANF) competitors?

A

Other companies in Can Fite Biopharma’s space includes: Dermata Therapeutics Inc (NASDAQ:DRMA), Acurx Pharmaceuticals Inc (NASDAQ:ACXP), Geovax Labs Inc (NASDAQ:GOVX), Genprex Inc (NASDAQ:GNPX) and Abpro Holdings Inc (NASDAQ:ABP).

Q

What is the forecast, or price target, for Can Fite Biopharma (CANF) stock?

A

Can Fite Biopharma has a consensus price target of $8.63.

Q

What is the current price for Can Fite Biopharma (CANF)?

A

The stock price for Can Fite Biopharma (AMEX: CANF) is $4.05 last updated February 3, 2026 at 8:00 PM EST.

Q

Does Can Fite Biopharma (CANF) pay a dividend?

A

There are no upcoming dividends for Can Fite Biopharma.

Q

When is Can Fite Biopharma (AMEX:CANF) reporting earnings?

A

Can Fite Biopharma does not have any upcoming earnings scheduled.

Q

Is Can Fite Biopharma (CANF) going to split?

A

There is no upcoming split for Can Fite Biopharma.

Q

What sector and industry does Can Fite Biopharma (CANF) operate in?

A

Can Fite Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

People Also Watch

Dermata Therapeutics Inc

NASDAQ:DRMA

$2.00

8.70%

Acurx Pharmaceuticals Inc

Indaptus Therapeutics Inc

NASDAQ:INDP

$1.91

3.24%

Alaunos Therapeutics Inc

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$4.13

Close

$4.05

Volume / Avg.

21.94K / 29.87K

Day Range

$4.00 - $4.17

52 Wk Range

3.63 - 6.99K

Market Cap

$5.30M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

21

Short Interest

310.74%

Days to Cover

1

Recent Can Fite Biopharma Ltd News

Why Aptevo Therapeutics Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Avi Kapoor

Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

UiPath, Ramaco Resources And 3 Stocks To Watch Heading Into Wednesday

U.S. stock futures slightly lower. UiPath joins S&P Midcap 400, Agios receives FDA approval, Can Fite Biopharma announces reverse split.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-8.35M

Investing Cash Flow (TTM)

-2.00K

Financing Cash Flow (TTM)

10.08M

Free Cash Flow (TTM)

-8.36M

Capital Expenditure (TTM)

-2.00K

Net Change in Cash (TTM)

1.73M

Analyst Trends and Forecast

2

Sep 25

2

Nov 25

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$722.83K

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.65

PB Ratio (TTM)

1.29

Earnings Yield % (TTM)

0.00%

Earnings Yield % (FWD)

-21.79%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.20

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$6.45M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$4.13

Close

$4.05

Volume / Avg.

21.94K / 29.87K

Day Range

$4.00 - $4.17

52 Wk Range

3.63 - 6.99K

Market Cap

$5.30M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

21

Short Interest

310.74%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and rela...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry